Last $165.03 USD
Change Today -2.92 / -1.74%
Volume 678.3K
As of 2:10 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitleKey Developments
Max Link Ph.D. 69 RelationshipsChairman of The Board, Member of Audit Committee and Member of Pharmaceutical Compliance & Quality Committee 
R. Norby 54 RelationshipsDirector, Chairman of Audit Committee, Chairman of Risk Committee and Member of Nominating & Corporate Governance Committee 
Andreas Rummelt Ph.D. 17 RelationshipsDirector, Chairman of Pharmaceutical Compliance & Quality Committee, Member of Audit Committee and Member of Risk Committee 

Compensation Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitle
William Keller 49 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
Alvin Parven 11 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Ann Veneman J.D. 61 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
ALXN Compensation vs. Industry
1.2M
363.0K
Chief Executive Officer
615.0K
270.0K
Chief Financial Officer
Share price activity for ALEXION PHARMACEUTICALS INC (ALXN)
52 Week Price Performance
ALXN
Industry Average

Nominating Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitleKey Developments
R. Norby 54 RelationshipsDirector, Chairman of Audit Committee, Chairman of Risk Committee and Member of Nominating & Corporate Governance CommitteeAlexion Pharmaceuticals, Inc. Announces Executive Appointments
09/17/14
Alvin Parven 11 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeAlexion Pharmaceuticals, Inc. Announces Board of Directors Appointments
07/16/14
William Keller 49 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk CommitteeAlexion Pharmaceuticals Inc. Announces Board Changes
04/17/14
Ann Veneman J.D. 61 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk CommitteeAlexion Pharmaceuticals, Inc. Announces Executive Changes
04/25/13

Corporate Governance Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitle
William Keller 49 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
R. Norby 54 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Alvin Parven 11 RelationshipsDirector, Member of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Risk Committee
Ann Veneman J.D. 61 Relationships--
ALXN and Competitor
Insiders vs. External
Board
17%
83%
Alexion Pharmaceuticals, Inc.
27%
73%
Illumina Inc.
25%
75%
Regeneron Pharmaceuticals, Inc.
17%
83%
Vertex Pharmaceuticals Incorporated
10%
90%
Sigma-Aldrich Corporation
13%
87%
Dr. Reddy's Laboratories Ltd.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $165.12 USD -2.83

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,230 INR +21.40
Illumina Inc $163.66 USD -1.56
Regeneron Pharmaceuticals Inc $359.02 USD +4.06
Sigma-Aldrich Corp $135.93 USD -0.35
Vertex Pharmaceuticals Inc $111.68 USD -2.22
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 84.3x
Price/Sales 17.3x
Price/Book 11.5x
Price/Cash Flow 82.7x
TEV/Sales 16.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.